Drug Class
antibody-drug conjugate
Type
brand
Active Ingredient
sacituzumab
📋Overview
Trodelvy is a prescription medication that contains sacituzumab govitecan, an antibody-drug conjugate. It is primarily used in the management of certain types of advanced or metastatic cancers, particularly triple-negative breast cancer. Trodelvy works by targeting cancer cells and delivering a chemotherapy agent directly to them. It is generally considered for patients whose disease has progressed despite other treatments.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Trodelvy
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.